Tapewire

Nasdaq · USD

SQFT

Presidio Property Trust, Inc.

Export transactions ↓
Tapewire entity
8487
SEC CIK
0001080657
Parsed reports
235

Last 12 months

Inside the activity.

4 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202530
Jan 202600
Feb 202600
Mar 202600
Apr 202602
May 202600
Jun 202601
Jul 202600
Aug 202600
Sep 202610
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 02, 2020 Filed Jan 2, 2020 12:00 UTC
DAO-HADDOCK QUYEN THIChief Accounting Officer
GrantCOMMON STOCK - SERIES A 3,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-000024 · doc4.xml · nonDerivative · entry 1

DAO-HADDOCK QUYEN THI · CIK 0001764220 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,494

F1 · shares: Restricted shares granted pursuant to the Company's 2017 Incentive Award Plan. These shares vest annually in three (3) equal installments, beginning on 12/31/2020.

F1 · price: Restricted shares granted pursuant to the Company's 2017 Incentive Award Plan. These shares vest annually in three (3) equal installments, beginning on 12/31/2020.

Read SEC document
January 02, 2020 Filed Jan 2, 2020 12:00 UTC
Dubose Larry GeneDirector · D&O of affiliated companies
GrantCOMMON STOCK - SERIES A 20,548 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-000023 · doc4.xml · nonDerivative · entry 1

Dubose Larry Gene · CIK 0001438084 · Director · D&O of affiliated companies

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 138,043

F1 · shares: Restricted shares granted pursuant to the Company's 2017 Incentive Award Plan. These shares vest annually in three (3) equal installments, beginning on 12/31/2020.

F1 · price: Restricted shares granted pursuant to the Company's 2017 Incentive Award Plan. These shares vest annually in three (3) equal installments, beginning on 12/31/2020.

F2 · balance_after: The amount reported reflects 19,581 additional shares to correct discrepancies between amounts previously reported and current records.

Read SEC document
January 02, 2020 Filed Jan 3, 2020 11:00 UTC
Sragovicz AdamChief Financial Officer
GrantCOMMON STOCK - SERIES A 15,281 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-000492 · doc4.xml · nonDerivative · entry 2

Sragovicz Adam · CIK 0001727723 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,555

F3 · shares: Restricted shares granted pursuant to the Company's 2017 Incentive Award Plan. These shares vest annually in three (3) equal installments, beginning on 12/31/2020.

F3 · price: Restricted shares granted pursuant to the Company's 2017 Incentive Award Plan. These shares vest annually in three (3) equal installments, beginning on 12/31/2020.

Read SEC document
December 31, 2019 Filed Jan 3, 2020 01:49 UTC
KATZ GARY MORRISSVP, Asset Management
Tax withholdingCOMMON STOCK - SERIES A 7,044 $4.01 $28,246.44
Disclosure

SEC source: 0001209191-20-000474 · doc4.xml · nonDerivative · entry 1

KATZ GARY MORRIS · CIK 0001764243 · SVP, Asset Management

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,143

F1 · shares: Reporting Person elected to have the Company withhold shares otherwise issuable to cover tax liabilities in connection with shares scheduled to vest on 12/31/2019.

F1 · price: Reporting Person elected to have the Company withhold shares otherwise issuable to cover tax liabilities in connection with shares scheduled to vest on 12/31/2019.

F2 · balance_after: The amount reported reflects 2,411 additional shares to correct discrepancies between amounts previously reported and current records.

Read SEC document
December 31, 2019 Filed Jan 3, 2020 11:00 UTC
Sragovicz AdamChief Financial Officer
Tax withholdingCOMMON STOCK - SERIES A 21,102 $4.01 $84,619.02
Disclosure

SEC source: 0001209191-20-000492 · doc4.xml · nonDerivative · entry 1

Sragovicz Adam · CIK 0001727723 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,274

F1 · shares: Reporting Person elected to have the Company withhold shares otherwise issuable to cover tax liabilities in connection with shares scheduled to vest on 12/31/2019.

F1 · price: Reporting Person elected to have the Company withhold shares otherwise issuable to cover tax liabilities in connection with shares scheduled to vest on 12/31/2019.

F2 · balance_after: The amount reported reflects 8,042 additional shares to correct discrepancies between amounts previously reported and current records.

Read SEC document
December 31, 2019 Filed Apr 20, 2020 23:27 UTC Amendment
Sragovicz AdamChief Financial Officer
GrantCOMMON STOCK - SERIES A 8,788 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-025164 · doc4a.xml · nonDerivative · entry 1

Sragovicz Adam · CIK 0001727723 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,343

F1 · kind: Reporting Person elected to have the Company withhold shares otherwise issuable to cover tax liabilities in connection with shares scheduled to vest on 12/31/2019. The number of shares withheld for taxes was incorrectly reported; it should have been 12,314 or 8,788 lower than initially reported.

F1 · shares: Reporting Person elected to have the Company withhold shares otherwise issuable to cover tax liabilities in connection with shares scheduled to vest on 12/31/2019. The number of shares withheld for taxes was incorrectly reported; it should have been 12,314 or 8,788 lower than initially reported.

F1 · acquired: Reporting Person elected to have the Company withhold shares otherwise issuable to cover tax liabilities in connection with shares scheduled to vest on 12/31/2019. The number of shares withheld for taxes was incorrectly reported; it should have been 12,314 or 8,788 lower than initially reported.

Read SEC document
December 30, 2019 Filed Jan 2, 2020 12:00 UTC
Heilbron Jack KendrickDirector · Chief Executive Officer
PurchaseCommon Stock - Series A 3,098 $3.75 $11,617.50
Disclosure

SEC source: 0001209191-20-000030 · doc4.xml · nonDerivative · entry 2

Heilbron Jack Kendrick · CIK 0001437208 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Puppy Toes, Inc.

Disclosed balance after: 11,110

F4 · ownership.nature: Reporting Person is the controlling shareholder of Puppy Toes, Inc.

Read SEC document
August 02, 2019 Filed Aug 12, 2019 17:27 UTC
Ong LaureenDirector
GrantCommon Stock - Series A 3,125 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-045464 · doc4.xml · nonDerivative · entry 1

Ong Laureen · CIK 0001611365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,125

F1 · shares: Restricted shares granted pursuant the Non-Employee Director Equity Compensation Plan under the Company's 2017 Incentive Award Plan, which shares vest annually in three (3) equal installments, beginning on 12/31/2019.

F1 · price: Restricted shares granted pursuant the Non-Employee Director Equity Compensation Plan under the Company's 2017 Incentive Award Plan, which shares vest annually in three (3) equal installments, beginning on 12/31/2019.

Read SEC document
January 02, 2019 Filed Jan 4, 2019 19:37 UTC
Sragovicz AdamChief Financial Officer
GrantCommon Stock - Series A 45,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-001828 · doc4.xml · nonDerivative · entry 1

Sragovicz Adam · CIK 0001727723 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,334

F1 · shares: Special, one-time grant of shares pursuant to the Company's 2017 Incentive Award Plan, which shares vest annually in three (3) equal installments.

F1 · price: Special, one-time grant of shares pursuant to the Company's 2017 Incentive Award Plan, which shares vest annually in three (3) equal installments.

Read SEC document
January 01, 2019 Filed Jan 3, 2019 21:55 UTC
Bruen DavidDirector
GrantCommon Stock - Series A 6,250 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-001075 · doc4.xml · nonDerivative · entry 1

Bruen David · CIK 0001456713 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,656

F1 · shares: Shares granted pursuant to the Company's 2017 Incentive Award Plan and vest annually in three (3) equal installments.

F1 · price: Shares granted pursuant to the Company's 2017 Incentive Award Plan and vest annually in three (3) equal installments.

Read SEC document
January 01, 2019 Filed Jan 4, 2019 00:44 UTC
Heilbron Jack KendrickDirector · Chief Executive Officer
GrantCommon Stock - Series A 30,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-001457 · doc4.xml · nonDerivative · entry 1

Heilbron Jack Kendrick · CIK 0001437208 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 212,431

F1 · shares: Shares granted pursuant to the Company's 2017 Incentive Award Plan and vest annually in three (3) equal installments.

F1 · price: Shares granted pursuant to the Company's 2017 Incentive Award Plan and vest annually in three (3) equal installments.

Read SEC document
January 01, 2019 Filed Jan 4, 2019 00:01 UTC GrantCommon Stock - Series A 6,250 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-001375 · doc4.xml · nonDerivative · entry 1

Bullard Shirley Y · CIK 0001536354 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,061

F1 · shares: Shares granted pursuant to the Company's 2017 Incentive Award Plan and vest annually in three (3) equal installments.

F1 · price: Shares granted pursuant to the Company's 2017 Incentive Award Plan and vest annually in three (3) equal installments.

Read SEC document
January 01, 2019 Filed Jan 4, 2019 00:00 UTC GrantCommon Stock - Series A 6,250 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-001374 · doc4.xml · nonDerivative · entry 1

Rollings Sumner James · CIK 0001437209 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,758

F1 · shares: Shares granted pursuant to the Company's 2017 Incentive Award Plan and vest annually in three (3) equal installments.

F1 · price: Shares granted pursuant to the Company's 2017 Incentive Award Plan and vest annually in three (3) equal installments.

Read SEC document
January 01, 2019 Filed Jan 3, 2019 23:59 UTC GrantCommon Stock - Series A 6,250 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-001371 · doc4.xml · nonDerivative · entry 1

Dubose Larry Gene · CIK 0001438084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,090

F1 · shares: Shares granted pursuant to the Company's 2017 Incentive Award Plan and vest annually in three (3) equal installments.

F1 · price: Shares granted pursuant to the Company's 2017 Incentive Award Plan and vest annually in three (3) equal installments.

Read SEC document
January 01, 2019 Filed Jan 3, 2019 23:58 UTC GrantCommon Stock - Series A 6,250 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-001368 · doc4.xml · nonDerivative · entry 1

SCHWARTZ THOMAS E · CIK 0001234186 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,145

F1 · shares: Shares granted pursuant to the Company's 2017 Incentive Award Plan and vest annually in three (3) equal installments.

F1 · price: Shares granted pursuant to the Company's 2017 Incentive Award Plan and vest annually in three (3) equal installments.

Read SEC document
January 01, 2019 Filed Jan 3, 2019 23:52 UTC
Sragovicz AdamChief Financial Officer
GrantCommon Stock - Series A 15,281 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-001357 · doc4.xml · nonDerivative · entry 1

Sragovicz Adam · CIK 0001727723 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,334

F1 · price: Shares granted pursuant to the Company's 2017 Incentive Award Plan and vest annually in three (3) equal installments.

F2 · balance_after: Reflects a reduction of 52 shares to correct the number of vested and unvested shares held that was reported on Form 3.

Read SEC document
January 01, 2019 Filed Jan 3, 2019 19:24 UTC GrantCommon Stock - Series A 6,250 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-000765 · doc4.xml · nonDerivative · entry 1

Elsberry Kenneth Wayne · CIK 0001435966 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,766

F1 · shares: Shares granted pursuant to the Company's 2017 Incentive Award Plan and vest annually in three (3) equal installments.

F1 · price: Shares granted pursuant to the Company's 2017 Incentive Award Plan and vest annually in three (3) equal installments.

Read SEC document
January 01, 2019 Filed Jan 3, 2019 18:38 UTC GrantCommon Stock - Series A 7,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-000729 · doc4.xml · nonDerivative · entry 1

Allen William · CIK 0001476541 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,164

F1 · shares: Shares granted pursuant to the Company's 2017 Incentive Award Plan and vest annually in three (3) equal installments.

F1 · price: Shares granted pursuant to the Company's 2017 Incentive Award Plan and vest annually in three (3) equal installments.

Read SEC document
April 24, 2018 Filed Apr 24, 2018 18:57 UTC
Heilbron Jack KendrickDirector · Chief Executive Officer
PurchaseCommon Series A 951.6814 $4.75 $4,520.49
Disclosure

SEC source: 0001209191-18-025929 · doc4.xml · nonDerivative · entry 1

Heilbron Jack Kendrick · CIK 0001437208 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Puppy Toes, Inc.

Disclosed balance after: 8,011.6814

F1 · ownership.nature: Jack Heilbron is the controlling shareholder of Puppy Toes, Inc.

Read SEC document
January 01, 2018 Filed Apr 10, 2019 19:51 UTC
Dubose Larry GeneDirector · D&O of affiliated companies
GrantCommon Stock - Series A 14,074 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-024231 · doc4.xml · nonDerivative · entry 1

Dubose Larry Gene · CIK 0001438084 · Director · D&O of affiliated companies

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,914

F1 · shares: Shares granted pursuant to the Company's 2017 Incentive Award Plan and vest annually in three (3) equal installments.

F2 · balance_after: Reflects the amount of securities beneficially owned as reported on January 3, 2017 increased by the shares acquired as currently reported.

Read SEC document
January 01, 2018 Filed Apr 10, 2019 23:03 UTC
Heilbron Jack KendrickDirector · Chief Executive Officer
GrantCommon Stock - Series A 25,736 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-024311 · doc4.xml · nonDerivative · entry 1

Heilbron Jack Kendrick · CIK 0001437208 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 238,947

F1 · shares: Shares granted pursuant to the Company's 2017 Incentive Award Plan and vest annually in ten (10) equal installments.

F1 · price: Shares granted pursuant to the Company's 2017 Incentive Award Plan and vest annually in ten (10) equal installments.

F2 · balance_after: Reflects the amount of securities beneficially owned as reported on January 3, 2019 increased by the shares acquired as currently reported and an additional 780 shares to correct previously reported holdings.

Read SEC document
February 09, 2017 Filed Feb 9, 2017 23:02 UTC
Heilbron Jack KendrickDirector · Chief Executive Officer
PurchaseCommon Series A 500 $6.00 $3,000.00
Disclosure

SEC source: 0001209191-17-009204 · doc4.xml · nonDerivative · entry 2

Heilbron Jack Kendrick · CIK 0001437208 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Puppy Toes, Inc.

Disclosed balance after: 7,060

F1 · ownership.nature: Jack Heilbron is the controlling shareholder of Puppy Toes, Inc.

Read SEC document
February 09, 2017 Filed Feb 9, 2017 22:55 UTC PurchaseCommon Series A 500 $6.00 $3,000.00
Disclosure

SEC source: 0001209191-17-009198 · doc4.xml · nonDerivative · entry 1

Elsberry Kenneth Wayne · CIK 0001435966 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,015.598

Read SEC document
January 03, 2017 Filed Jan 3, 2017 23:30 UTC GrantCommon Series A 2,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-000445 · doc4.xml · nonDerivative · entry 1

SCHWARTZ THOMAS E · CIK 0001234186 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,894.929

F1 · price: Restricted Stock granted pursuant to Director and Officer Compensation Plan and subject to a three-year vesting period.

Read SEC document
January 03, 2017 Filed Jan 3, 2017 23:22 UTC GrantCommon Series A 2,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-000436 · doc4.xml · nonDerivative · entry 1

Rollings Sumner James · CIK 0001437209 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,508.213

F1 · price: Restricted Stock granted pursuant to Director and Officer Compensation Plan and subject to a three-year vesting period.

Read SEC document
January 03, 2017 Filed Jan 3, 2017 23:04 UTC
Pittard Heather LPrincipal Accounting Officer
GrantCommon Series A 3,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-000412 · doc4.xml · nonDerivative · entry 1

Pittard Heather L · CIK 0001639546 · Principal Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,923.12

F1 · price: Restricted Stock granted pursuant to Director and Officer Compensation Plan and subject to a three-year vesting period.

Read SEC document
January 03, 2017 Filed Jan 3, 2017 22:35 UTC
Heilbron Jack KendrickDirector · Chief Executive Officer
GrantCommon Series A 16,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-000381 · doc4.xml · nonDerivative · entry 1

Heilbron Jack Kendrick · CIK 0001437208 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 182,431.082

F1 · price: Restricted Stock granted pursuant to Director and Officer Compensation Plan and subject to a ten-year vesting period.

Read SEC document
January 03, 2017 Filed Jan 3, 2017 22:01 UTC
Harbert GrantChief Financial Officer
GrantCommon Series A 5,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-000333 · doc4.xml · nonDerivative · entry 1

Harbert Grant · CIK 0001671830 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

F1 · price: Restricted Stock granted pursuant to Director and Officer Compensation Plan and subject to a three-year vesting period.

Read SEC document
January 03, 2017 Filed Jan 3, 2017 21:53 UTC GrantCommon Series A 4,600 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-000308 · doc4.xml · nonDerivative · entry 1

Elsberry Kenneth Wayne · CIK 0001435966 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,515.598

F1 · price: Restricted Stock granted pursuant to Director and Officer Compensation Plan and subject to a three-year vesting period.

Read SEC document
January 03, 2017 Filed Jan 3, 2017 21:23 UTC
Bruen DavidDirector
GrantCommon Series A 2,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-000223 · doc4.xml · nonDerivative · entry 1

Bruen David · CIK 0001456713 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,405.853

F1 · price: Restricted Stock granted pursuant to Director and Officer Compensation Plan and subject to a three-year vesting period.

Read SEC document
January 03, 2017 Filed Jan 3, 2017 21:46 UTC GrantCommon Series A 8,750 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-000300 · doc4.xml · nonDerivative · entry 1

Dubose Larry Gene · CIK 0001438084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,839.96

F1 · price: Restricted Stock granted pursuant to Director and Officer Compensation Plan and subject to a ten-year vesting period.

Read SEC document
January 03, 2017 Filed Jan 3, 2017 20:51 UTC GrantCommon Series A 2,500 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-000150 · doc4.xml · nonDerivative · entry 1

Bullard Shirley Y · CIK 0001536354 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,810.868

F1 · price: Restricted Stock granted pursuant to Director and Officer Compensation Plan and subject to a three-year vesting period.

Read SEC document
January 03, 2017 Filed Jan 3, 2017 20:43 UTC GrantCommon Series A 3,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-000138 · doc4.xml · nonDerivative · entry 1

Allen William · CIK 0001476541 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,664.254

F1 · price: Restricted Stock granted pursuant to Director and Officer Compensation Plan and subject to a three-year vesting period.

Read SEC document
September 21, 2016 Filed Sep 21, 2016 19:13 UTC PurchaseCommon Series A 1,000 $6.50 $6,500.00
Disclosure

SEC source: 0001209191-16-142233 · doc4.xml · nonDerivative · entry 1

Elsberry Kenneth Wayne · CIK 0001435966 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,915.598

Read SEC document
September 21, 2016 Filed Sep 21, 2016 19:02 UTC
Heilbron Jack KendrickDirector · Chief Executive Officer
PurchaseCommon Series A 1,000 $6.50 $6,500.00
Disclosure

SEC source: 0001209191-16-142232 · doc4.xml · nonDerivative · entry 2

Heilbron Jack Kendrick · CIK 0001437208 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · Held by Puppy Toes, Inc.

Disclosed balance after: 6,560

F1 · ownership.nature: Jack Heilbron is the controlling shareholder of Puppy Toes, Inc.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.